Inhaled carbenoxolone prevents allergic airway inflammation and airway hyperreactivity in a mouse model of asthma

Ram, Arjun ; Singh, Shashi Kant ; Singh, Vijay Pal ; Kumar, Sarvesh ; Ghosh, Balaram (2009) Inhaled carbenoxolone prevents allergic airway inflammation and airway hyperreactivity in a mouse model of asthma International Archives of Allergy and Immunology, 149 (1). pp. 38-46. ISSN 1018-2438

Full text not available from this repository.

Official URL: http://content.karger.com/ProdukteDB/produkte.asp?...

Related URL: http://dx.doi.org/10.1159/000176305

Abstract

Background: Asthma is a chronic respiratory disease, which needs a safer medication preferably in inhalation form. In view of this, we have evaluated the effect of inhaled carbenoxolone (CBX), a herbal-derived compound, on asthma in a mouse model. Methods: Mice were sensitized and challenged with ovalbumin (OVA) to develop certain characteristic features of asthma such as airway hyperreactivity (AHR), airway eosinophilia, lung inflammation and mucus hypersecretion. To evaluate the effect of CBX on the above asthmatic features, CBX (2.5, 5 and 10 mg/ml, 3 ml) or vehicle (water) was given by inhalation. AHR was determined using whole-body plethysmography. Infiltration of eosinophils was estimated by microscopy. Lung inflammation and mucus hypersecretion were assessed using hematoxylin and eosin, and periodic acid-Schiff staining, respectively. Th-2 cytokines, IL-4 and IL-5 were measured in bronchoalveolar lavage (BAL) fluid and IgE in sera. To identify the possible mode of CBX action, we measured corticosterone levels in the BAL fluid and 5-lipoxygenase (5-LO) expression in the lungs. Results: CBX (5 mg/ml) inhalation markedly alleviated AHR (p = 0.0032) and reduced lung inflammation and mucus hypersecretion. Also, it prevented the increase in IL-4 (p = 0.0192), IL-5 (p = 0.0116) and eosinophils (p < 0.0005) in the BAL fluid, and OVA-specific IgE levels (p = 0.00061) in sera. 5-LO expression was also markedly reduced. However, corticosterone levels were not affected. Conclusions: Inhaled CBX alleviates the asthmatic features in mice and could be a potent nebulized therapy in clinical asthma.

Item Type:Article
Source:Copyright of this article belongs to S. Karger AG.
Keywords:Airway Hyperreactivity; Airway Inflammation; Carbenoxolone; Cytokines; Eosinophils; Mucus Secretion
ID Code:66013
Deposited On:21 Oct 2011 03:35
Last Modified:21 Oct 2011 03:35

Repository Staff Only: item control page